Table 2.
N (%) | M (SD) | n (Missing) | |
---|---|---|---|
cancer Diagnosis | 1 | ||
First/Initial | 317 (97.2%) | ||
Recurrence | 9 (2.8%) | ||
Months Since Diagnosis | 10.11 (6.21) | 0 | |
Stage | 0 | ||
I | 183 (56.0%) | ||
II | 113 (34.6%) | ||
III | 31 (9.5%) | ||
Breast Surgery History | |||
Mastectomy – one breast | 54 (16.7%) | 3 | |
Mastectomy – two breasts | 65 (20.1%) | 3 | |
Breast Conserving Surgery | 185 (56.9%) | 2 | |
Lymph Node Removal | 286 (88.3%) | 3 | |
Reconstruction | 73 (22.5%) | 3 | |
Receipt of chemotherapy | 27 (8.3%) | 1 | |
Receipt of Radiation | 35 (10.8%) | 2 | |
Receipt of surgery | 22 (6.7%) | 1 | |
Receipt of endocrine therapy | 49 (15.1%) | 3 | |
Receipt of immunotherapy | 31 (9.6%) | 4 | |
Antidepressant medication use | 123 (37.7%) | 1 | |
Pain medication use | 212 (64.8%) | 0 | |
Days with pain medication use | 4 | ||
0 | 118 (36.5%) | ||
1 | 15 (4.6%) | ||
2 | 22 (6.8%) | ||
3 | 34 (10.5%) | ||
4 | 28 (8.7%) | ||
5 | 18 (5.6%) | ||
6 | 3 (.9%) | ||
7 | 85 (26.3%) | ||
Type of pain medication | |||
OTC | 177 (54.1%) | 0 | |
Opioid | 60 (18.3%) | 0 | |
Corticosteroid | 8 (2,4%) | 0 | |
Anti-epileptic (e.g, Neurontin) | 30 (9.2%) | 0 | |
Anxiolytic | 48 (14.7%) | 0 |
Note. M = mean; SD = standard deviation; Breast-conserving Surgery includes lumpectomy, quadrantectomy, partial mastectomy, segmental mastectomy; Receipt of chemotherapy, radiation, surgery, endocrine therapy, and immunotherapy is for week before baseline assessment; OTC = over the counter.